Ser730

Site Information
RDsGCyEsSENLENG SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 484145

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	breast cancer ( 2 ) , breast cancer, triple negative ( 2 ) , melanoma skin cancer ( 1 )
Relevant cell line - cell type - tissue:	breast ( 2 ) , WM239A (melanocyte) ( 1 )

Upstream Regulation
Treatments:	ischemia ( 2 )

References
1	Stuart SA, et al. (2015) A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics 14, 1599-615 25850435 Curated Info
2	Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704 24719451 Curated Info